SCHEMBL23958159

SCHEMBL23958159

COc1ccnc(Nc2nc3ccc(F)cc3c(=O)n2-c2ccccc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 4/20 0.45
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PIK3CG P48736 4/20 0.41
PI4KA P42356 3/20 0.41
MEN1 O00255 1/20 0.41
USP2 O75604 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
TSHR P16473 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
PIK3CD O00329 1/20 0.41
PIK3C3 Q8NEB9 1/20 0.41
TP53 P04637 1/20 0.41
TDO2 P48775 1/20 0.40
IDO2 Q6ZQW0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24111048 0.88 TDO2 (0.46) HTR7POLBPIK3CGPI4KAPIK3CD
SCHEMBL30103221 0.88 TDO2 (0.46) HTR7POLBPIK3CGPI4KAPIK3CD
SCHEMBL24110965 0.87 POLB (0.49) HTR7POLBSMN1; SMN2PIK3CGPIK3CD
SCHEMBL23958333 0.86 HTR7 (0.45) HTR7PIK3CGPI4KAMEN1USP2
SCHEMBL23958125 0.84 MAT2A (0.47) HTR7POLBPIK3CGPI4KAPIK3CD
SCHEMBL30103197 0.83 PIK3CB (0.47) HTR7POLBPIK3CGPI4KAPIK3CD
SCHEMBL24110790 0.83 PIK3CB (0.47) HTR7POLBPIK3CGPI4KAPIK3CD
SCHEMBL24111017 0.82 PIK3CG (0.40) HTR7POLBPIK3CGPI4KAALDH1A1
SCHEMBL23958170 0.82 POLB (0.42) HTR7POLBPIK3CGPI4KAMEN1
SCHEMBL24111027 0.82 HTR7 (0.42) HTR7POLBPIK3CGPI4KAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2021-12-16 US disclosed
WO-2021215537-A1 2-HETEROARYLAMINOQUINAZOLINONE DERIVATIVE 大日本住友製薬株式会社 (JP) 2021-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387967-A1 2-HETEROARYL AMINOQUINAZOLINONE DERIVATIVE CRKL, CLIC4, CLIC1 HTR7 1211/4885POLB 4618/4885SMN1; SMN2 3266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.